Ptc Therapeutics (PTCT) Short-term Investments (2013 - 2026)

Ptc Therapeutics' Short-term Investments history runs 14 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• On a quarterly basis, Short-term Investments rose 93.52% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 93.52% increase from a year earlier, with the FY2025 full-year figure at $960.7 million, up 166.88% from the prior year.
• Short-term Investments improved to $1.1 billion in Q1 2026 per PTCT's latest filing, from $960.7 million in the prior quarter.
• Across five years, Short-term Investments topped out at $1.1 billion in Q1 2026 and bottomed at $118.8 million in Q1 2023.
• The 5-year median for Short-term Investments is $360.0 million (2024), against an average of $467.2 million.
• Across the five-year window, Short-term Investments slumped 77.58% in 2022 and soared 275.89% in 2024, its largest moves.
• Year by year, Short-term Investments stood at $130.9 million in 2022, then jumped by 116.04% to $282.7 million in 2023, then climbed by 27.32% to $360.0 million in 2024, then jumped by 166.88% to $960.7 million in 2025, then climbed by 10.18% to $1.1 billion in 2026.
• Per Business Quant, the three latest PTCT Short-term Investments figures stand at $1.1 billion (Q1 2026), $960.7 million (Q4 2025), and $1.0 billion (Q3 2025).